Pregnant Mothers with Resolved Anxiety Disorders and Their Offspring Have Reduced Heart Rate Variability: Implications for the Health of Children by Braeken, MAKA et al.
Pregnant Mothers with Resolved Anxiety Disorders and
Their Offspring Have Reduced Heart Rate Variability:
Implications for the Health of Children
Marijke A. K. A. Braeken1,2, Andrew H. Kemp3,4,5, Tim Outhred3,4, Renée A. Otte1, Geert J. Y. J. Monsieur6,7,
Alexander Jones8, Bea R. H. Van den Bergh1,9*
1 Department of Developmental Psychology, Tilburg University, Tilburg, The Netherlands, 2 REVAL Rehabilitation Research Center, Biomedical Research
Institute, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium, 3 SCAN Research & Teaching Unit, School of Psychology, University of
Sydney, Sydney, New South Wales, Australia, 4 CADE Clinic, Discipline of Psychiatry, Sydney Medical School, University of Sydney, Sydney, New South
Wales, Australia, 5 Hospital Universitário, University of São Paulo, São Paulo, Brazil, 6 ERISS, European Research Institute in Service Science, Department of
Information Management, Tilburg University, Tilburg, The Netherlands, 7 LIRIS, Department of Information Management, KU Leuven, Leuven, Belgium,
8 Institute of Cardiovascular Science, University College London, London, United Kingdom, 9 Department of Psychology, KU Leuven, Leuven, Belgium
Abstract
Objective: Active anxiety disorders have lasting detrimental effects on pregnant mothers and their offspring but it is
unknown if historical, non-active, maternal anxiety disorders have similar effects. Anxiety-related conditions, such as
reduced autonomic cardiac control, indicated by reduced heart rate variability (HRV) could persist despite disorder
resolution, with long-term health implications for mothers and children. The objective in this study is to test the
hypotheses that pregnant mothers with a history of, but not current anxiety and their children have low HRV,
predicting anxiety-like offspring temperaments.
Methods: The participants in this case-control study consist of 56 women during their first trimester and their
offspring (15 male, 29 female). Women had a history of an anxiety disorder (n=22) or no psychopathology (n=34)
determined using the Mini-International Neuropsychiatric Interview. The main outcome measures were indices of
autonomic cardiac control including root mean square of successive differences (RMSSD) and high frequency (HF)
variability. Children’s fearfulness was also assessed using the Laboratory Temperament Assessment Battery (Lab-
TAB)-Locomotor Version.
Results: HRV was lower in women and children in the past anxiety group compared to controls. HRV measures for
mothers and children were positively correlated in the anxiety group only. In all children, low HRV measures at 2-4
months were associated with a higher chance of fearful behavior at 9-10 months.
Conclusions: Pregnant women with previous but not current anxiety and their children have low HRV. Children with
low HRV tend to show more fearfulness. These findings have implications for identifying children at risk of anxiety
disorders and point to possible underlying mechanisms of child psychopathology.
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Introduction
More than one third of adults have a history of anxiety
disorders and women are twice as likely to experience such
disorders [1]. Though the presence of anxiety disorders during
pregnancy has an impact on both mothers and their offspring
[2,3], it is not known if a resolved anxiety disorder is similarly
important. Mood and anxiety disorders are associated with
abnormal autonomic nervous system (ANS) function, indexed
by reduced heart rate variability (HRV). Reduced HRV is a
marker of physical and mental ill health and has been identified
as a risk factor for various diseases, including cardiovascular
disease (CVD) and mortality [4-8]. If autonomic abnormalities
(e.g., low HRV) also persist in pregnant women who have had
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an anxiety disorder, these could have important, under-
appreciated health risks in both, mothers and their children.
However, it is not known whether past mental disorders could
affect pregnant women and their children via reduced HRV, or
other uncharacterized mechanisms. HRV of the developing
fetus is altered in the offspring of mothers with a number of
psychiatric conditions, including anxiety disorders, and these
differences persist postnatally [9-11]. This suggests that the
development of the ANS may be susceptible to the influence of
maternal characteristics, with potential long-term
consequences for the health of the offspring. Therefore,
improved understanding of the relationship between maternal
psychiatric illness, HRV and infant physical and mental
wellbeing is an important goal.
In this study, we aimed to assess the physiological correlates
of past maternal anxiety disorders in both pregnant mothers
and their offspring, focusing on HRV as a potential shared risk
factor for ill health and abnormal autonomic function. To
optimize our study, HRV was measured at rest and during
mental stress. Although associations with HRV are apparent at
rest [12,13], they are often more evident when participants are
exposed to stress [14], and anxious individuals may be
particularly sensitive to such stress exposure [15,16]. We
assessed HRV in mothers with a remitted anxiety disorder and
healthy controls in their first trimester of pregnancy, a critical
period of fetal development. We then assessed the HRV of
their offspring at 2-4 months of age and the child’s
temperament at 9-10 months.
We hypothesized the following: 1) mothers with a past, but
no current, anxiety disorder will demonstrate abnormal
autonomic physiology (particularly low HRV); 2) these
differences will be more apparent under stress than under rest;
3) maternal HRV will be positively correlated with offspring
HRV; 4) offspring of mothers with a history of an anxiety
disorder will display abnormal autonomic physiology (low HRV)
and; 5) this will be associated with temperamental disturbances




Participants in the present study were recruited as part of the
Prenatal Early Life Stress (PELS) study by midwives and
hospitals, between May 2009 and July 2010. The overarching
goal of PELS is to study the associations between prenatal risk
factors, birth outcome and altered child psychophysiology and
neurodevelopment. For the purposes of the present study, a
group of women with a past, but no current, anxiety disorder
(PAD group) and a healthy control group without any history of
psychopathology were defined. No participants with a current
diagnosis of an anxiety disorder were available from the PELS
study. PAD included panic disorder, agoraphobia, generalized
anxiety disorder, social phobia, obsessive-compulsive disorder
and posttraumatic stress disorder. In the PAD group, 17
women had only one of these anxiety diagnoses, while five
women had two of them. Nine women also had a history of
comorbid depression and five had a history of a comorbid
eating disorder. None of the participants were under treatment
for a current mental disorder, used cardiovascular medications
or antidepressants. Loss to follow-up or attrition due to data
loss in the groups is shown in Figure 1.
Figure 1.  Consort diagram.  This figure shows the loss to follow-up or attrition in the study participants.
doi: 10.1371/journal.pone.0083186.g001
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Ethics Statement
The Medical Ethics Committee of the St. Elisabeth hospital in
Tilburg (the Netherlands) approved the study. All participants
provided informed, written consent for themselves and their
children.
Procedures
Psychological and Psychiatric Assessment of
Mothers.  The Mini-International Neuropsychiatric Interview 6.0
[17] was administered within the second pregnancy trimester to
assess past maternal psychopathology. This is a structured
interview based on Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition (DSM-IV) criteria. In the first pregnancy
trimester women completed the state anxiety subscale of the
State Trait Anxiety Inventory [18]. The women rated
themselves on twenty items on a four-point Likert scale ranging
from “(1) - not at all” to “(4) - very much”, resulting in an anxiety
total score ranging between 20 and 80.
Relaxation and Stress Tasks.  In the first pregnancy
trimester each mother undertook a 25-minute task that
consisted of five testing phases, lasting 5 minutes each. Stress
was induced in the second and fourth phase, with the
remainder being relaxation phases. During the stress phases,
participants were asked to solve complex mental arithmetic
problems, involving five mathematical operations on 2-3 digit
numbers without verbalization (e.g., (361+11)÷(3× 4)+137).
They were asked to choose the correct answer from three
possibilities presented by a computer. Feedback on the task
was given after completion of the last phase [19]. Participants
viewed peaceful pictures and listened to restful music during
the relaxation phase [20].
ECG Recording.  During the relaxation and stress tasks
maternal ECG was recorded using the Vrije Universiteit
Ambulatory Monitoring system (VU-AMS) [21] in a three Ag/
AgCl electrode placement configuration: (1) on the sternum
over the ﬁrst rib between the two collarbones, (2) at the apex of
the heart over the ninth rib on the left lateral margin of the
chest, and (3) at the lower right abdomen (ground electrode).
The skin was cleaned with alcohol to ensure impedance was
low. Five-minute HRV measurements were determined for the
relaxation and stress phases separately.
Children’s ECGs were collected when they were 2-4 months
of age. The active electrode was placed on the child’s thorax,
while the reference and ground electrode were on an EEG cap
[22]. These recordings were made using a Biosemi ActiveTwo
biopotential measurement system. Although some data were
discarded due to motion artifacts, HRV measurements were
determined from the average of 3 to 5 blocks of ECG, lasting
2.5 minutes each.
Behavioral Assessment of the Children.  An additional
assessment of child behavior at 9-10 months of age was
conducted using the Laboratory Temperament Assessment
Battery (Lab-TAB)-Locomotor Version [23], a more ecologically
valid and less biased assessment of child behavior and
temperament than parental-report measures with demonstrable
clinical value [24]. The child was presented with a robotic dog
(the unpredictable mechanical toy paradigm from the fear
subscale) that was barking and walking towards them. Based
on the children’s facial expression, body posture, vocalizations,
and escape behavior, indicators of fear were assessed for the
first 20 seconds [25]. A researcher, blind to maternal data,
rated the recorded videotapes using the standard scoring
procedures. Observed fearfulness was calculated from the fear
indicators. As the fearfulness measure could not be
normalized, children with a score of 0 or 1 were categorized as
not fearful, while children with a score above 1 were
considered fearful.
Data Processing and Analyses
ECG data were processed using custom software written in
Matlab (Mathworks, Natick, USA) to obtain indices of
parasympathetic ANS activity, according to published
standards [26]. These measures were root mean square of
successive differences (RMSSD) and high frequency (HF)
variability. ECG beat detection was carried out with the Hilbert
transform algorithm [27]. Potentially erroneous beat detections
were identified using a standard approach and screened for
validity [28]. As HRV measures were right-skewed, they were
natural log transformed to normality. Data for three mothers
were excluded due to extreme values; visual inspection of the
ECGs suggested that these outliers were due to cardiac
arrhythmias.
Statistical analyses were performed using SPSS 19 [29]. A
repeated measures ANOVA was used to examine the
differences between mothers’ HRV during the various phases
of the mental arithmetic task across the two groups (healthy
group versus PAD group). Mother’s age and pre-pregnancy
BMI were included as covariates. To account for mothers’ state
anxiety, we conducted a propensity score matching to balance
state anxiety, age and BMI in both groups. This procedure was
executed using a custom designed plugin [30] for IBM SPSS
Statistics. Logistic regression is used to determine a predicted
score that relates to the propensity for participants to belong to
a particular group based on a given set covariates. The
matching algorithm was fine-tuned by discarding units outside
the area of common support to improve balance on covariates,
and using a ‘caliper’ of 0.5 – this is the standard deviation of
the logit of the propensity score – to prevent ‘bad’ matches.
After the propensity score is estimated, cases with the closest
score are matched using a simple 1:1 nearest neighbor
matching routine based on a ‘greedy’ matching algorithm. A
series of model adequacy checks were then performed
including inspection of numerical balance measures, diagnostic
plots and re-examination of group differences across the
covariates entered into the PS analysis. Next, mothers’ state
anxiety was added as covariate in the repeated measures
ANOVA. Independent t-tests were conducted to investigate
group differences in children’s HRV. Linear regression
analyses were conducted to determine whether maternal HRV
was associated with that of their children, and logistic
regression analyses to determine whether children’s HRV at
2-4 months of age was associated with fearfulness at 9-10
months of age. Regression analyses were controlled for sex,
age, birth weight, and gestation length of the child and mother’s
state anxiety. The effect of offspring HRV on the continuous
variable fearfulness was also tested for significance by
Past Maternal Anxiety, HRV & Child's Temperament
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generating bootstrapped 95% confidence intervals as the
fearfulness variable was not normal.
Results
Participant Characteristics
Characteristics of mothers and children in the healthy and
PAD groups are shown in Table 1. Importantly, no differences
between groups were observed for variables that might have a
confounding influence on HRV, except for mothers’ state
anxiety. Age and BMI of mothers, and age, sex distribution,
birth weight, fearfulness and gestation length of the children did
not differ significantly between the groups. Propensity score
matching identified and matched 18 mothers in each group,
providing a matched sample across all of the critical
confounding factors, including mothers’ state anxiety.
Table 1. Comparison of mean (SD) characteristics of
mothers and children in the healthy group versus the past
anxiety disorder group.
 Healthy Past anxiety p-value
Mothers    
N 34 22  
AGE (yr) 34.31 (3.14) 33.47 (4.95) .44
BMI (kg/m2) 24.51 (4.98) 24.13 (3.13) .75
STAI (state)a 33.29 (5.79) 39.05 (6.98) .001
RMSSD Phase 1 (rest) (ln ms) 3.46 (0.53) 3.2 (0.44) .06
RMSSD Phase 2 (stress) (ln ms) 3.31 (0.48) 2.92 (0.48) .005
RMSSD Phase 3 (rest) (ln ms) 3.38 (0.45) 3.15 (0.51) .08
RMSSD Phase 4 (stress) (ln ms) 3.28 (0.43) 3.08 (0.51) .13
RMSSD Phase 5 (rest) (ln ms) 3.47 (0.46) 3.17 (0.45) .02
HF Phase 1 (rest) (ln ms2) 6.16 (1.02) 5.69 (0.77) .07
HF Phase 2 (stress) (ln ms2) 5.92 (0.92) 5.25 (0.86) .009
HF Phase 3 (rest) (ln ms2) 5.99 (0.91) 5.49 (0.93) .05
HF Phase 4 (stress) (ln ms2) 5.97 (0.72) 5.39 (0.8) .006
HF Phase 5 (rest) (ln ms2) 6.25 (0.84) 5.54 (0.85) .003
Children at 2-4 months
N 28 16  
Age (wk) 15.2 (5.1) 16.6 (6.2) .41
Sex 8 boys, 20 girls 7 boys, 9 girls .31f
Gestation (wk) 39.4 (1.1) 39.1 (2.1) .54
Birth weight (g) 3330 (348) 3269 (562) .87
RMSSD Rest (ln ms) 2.47 (0.51) 2.16 (0.44) .048
HF Rest (ln ms2) 4.43 (1.04) 3.78 (1.00) .048
Children at 9-10 months
N 15 7  
Age (wk) 35.7 (3.1) 35.7 (3.6) >.99
Sex 4 boys, 11 girls 4 boys, 3 girls .17b
a Analysis focused on the state anxiety subscale of the STAI (20 items measuring
the intensity of anxiety-related symptoms).
b X2 test
doi: 10.1371/journal.pone.0083186.t001
Impact of Past Anxiety Disorder in Women
Repeated measures ANOVA analysis, adjusted for mother’s
age and pre-pregnancy BMI, revealed a significant between-
subjects effect of group (i.e. PAD or healthy) on both RMSSD
HRV (RMSSD: F(1,52)=4.37, p=.04, partial η2=0.08) and HF
HRV (HF: F(1,52)=6.68, p=.01, partial η2=0.12), indicating
reduced HRV in women with PAD (Figure 2, a and b). In
addition, there was a significant within-subjects effect of phase,
indicating that mothers’ HRV was significantly different across
phases (RMSSD: F(1,52)=11.16, p<.001, partial η2=0.18 HF:
F(1,52)=5.73, p<.001, partial η2=0.10) (see Table 1). There was
no interaction effect of group by phase, therefore, subsequent
analyses are based on the mean HRV over all five phases,
since the aim of our study was to study differences between
women with a PAD and the healthy group. Between-subjects
effects of group remained significant for HF HRV
(F(1,36)=4.23, p=.048, partial η2=0.12), but not for RMSSD
(F(1,36)=1.60, p=.22, partial η2=0.05) when tests were run on
the propensity score matched sample.
Associations Between Maternal and Offspring HRV
Regression analysis, adjusted for mother’s state anxiety,
offspring’s sex and age, revealed a significant group x mother’s
HRV interaction effect on offspring’s HRV RMSSD (β=0.98, p=.
01) and HRV HF (β=0.95, p=.046), indicating that there is a
positive significant association between maternal and offspring
HRV in the PAD group, but not in the healthy group. Adding
birth weight and gestation length as additional covariates
showed that the relationship between maternal and infant HRV
was not influenced by changes in birth weight and gestational
age.
Impact of Maternal Past Anxiety Disorder on Offspring
HRV
An independent t-test showed that children of mothers with a
PAD have lower HRV than those born to mothers without a
PAD (RMSSD t(42)=2.04, p=.048, Hg=.65; HF t(42)=2.05, p=.
048, Hg=.65; Table 1 and Figure 2, c and d). Maternal state
anxiety was inversely correlated with offspring RMSSD HRV
but this had marginal significance (r=-0.27, p=.08), while the
correlation for HF HRV was significant (r=-0.33, p=.03). These
were correlations in the total group (consisting of the healthy
group and PAD group); no correlations were found between
maternal state anxiety and offspring HRV when focusing on
groups separately (p>.05).
Relationship between Offspring Temperament and
Offspring HRV
Logistic regression analyses controlling for age, sex and
gestation length indicated that the children’s HRV at 2-4
months of age was inversely associated with measures of their
fearfulness carried out at 9-10 months of age (RMSSD: odds
ratio=0.01, p=.047; HF: odds ratio=0.20, p=.07). Bootstrapped
regression analyses with fearfulness as a continuous variable
also indicated a significant effect of offspring HRV on
fearfulness (RMSSD: 95% CI=[-1.63, -1.19]; HF: 95%
CI=[-0.09, -0.01]).
Past Maternal Anxiety, HRV & Child's Temperament
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Discussion
To our knowledge, this is the first study to show that
pregnant women with a PAD have autonomic abnormalities
early in pregnancy and that these abnormalities may impact on
the future physiological (reduced parasympathetic function)
and mental (fearfulness) wellbeing of their offspring. Pregnant
women with PAD displayed reduced parasympathetic nervous
system activity (indexed by HRV), compared to those without
PAD. Furthermore, the offspring of mothers with a PAD also
had lower HRV than those whose mothers had been healthy. In
the group of mothers with PAD, an association between
maternal HRV and offspring HRV was observed. In the
offspring, lower HRV at 2-4 months was associated with a
fearful temperament assessed approximately 7 months later.
These findings were independent of variations in state-anxiety,
age, sex, BMI and mother-child associations were not
explained by the children’s birth weight or gestational age.
Consistent with prior research, this study shows that people
with past psychiatric disorders have lower HRV [6-8,31]. The
novel contribution we make here is the result that pregnant
women with a past anxiety disorder also have reduced HRV
and these psychophysiological alterations may impact on the
future physiological and mental wellbeing of their offspring. It is
important to note that the HF HRV differences between women
with and without PAD – findings associated with a moderate to
large effect size – remained after controlling for confounding
factors including state anxiety, age and BMI by propensity
score matching. Future studies are needed to confirm this
finding in a larger sample in order to generalize to both
pregnant and non-pregnant women populations. We note here
that women with PAD have a higher level of a subclinical trait
(e.g., anxiety), although it no longer reaches criteria for clinical
diagnosis. Although we controlled for state anxiety as a
confounding factor, it is possible that state anxiety also impacts
on maternal HRV as well as the physiological and mental state
of the offspring.
There are numerous possible means by which maternal PAD
and/or HRV might be associated with parasympathetic nervous
system function in the offspring. Clearly, mothers and their
children share genes and environmental exposures and the
health of mothers in pregnancy is an important determinant of
child development and health. Maternal behavior may also be
an important factor in this association [32-34]. In our study, the
mothers with a PAD not only had significantly lower HRV
compared to the healthy group, but also had altered state
anxiety, albeit to a lesser extent than in the past. In comparison
to the healthy group, the offspring of mothers with a PAD also
had lower HRV. Lower HRV in all children was shown to be
associated with a fearful temperament. Therefore, it is possible
that mothers with a PAD and their offspring share an
underlying psychological disorder, which might explain links
between maternal and offspring HRV. Our study highlights the
Figure 2.  Comparison of between healthy group and the past anxiety disorder group.  This figure shows for both mother and
child the differences in HRV between the healthy group and the past anxiety disorder group.
doi: 10.1371/journal.pone.0083186.g002
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need for more research into how mothers might transmit their
pro-anxiety phenotype to their offspring.
A variety of genes influence vulnerability to anxiety disorders.
These include serotonin-transporter linked polymorphic region
(5-HTTLPR), Catechol-O-methyltransferase (COMT), and
brain-derived neurotrophic factor (BDNF) gene variants [35].
We have reported previously that the combination of a BDNF
V/V genotype and early life stress predicts changes in brain
structure that are associated with lower HRV and higher
anxiety [36]. These findings provide a potential explanation for
our observed relationship between HRV of mothers with a PAD
and their children, but not in healthy controls.
Another possibility is that altered autonomic function in
pregnant mothers may impact on the development of their
offspring, as a form of developmental programming. Reduced
HRV is associated with dysregulation of various allostatic
systems, including glucose regulation, hypothalamic-pituitary-
adrenal (HPA) axis function and inflammatory processes [37],
all of which may program fetal development [38-44]. However,
it is not clear whether the abnormal ANS function, reflected by
lower HRV, is an important causative factor in these disorders,
or simply the result of shared underlying processes.
Observed fearfulness in the children at 9 months was
associated with their HRV at 2-4 months. It is possible that 9
month olds with higher fearfulness already had characteristics
of a fearful temperament at 2-4 months, which could explain
the association between reduced HRV and future fearful
temperament as a persistence of these related factors.
However, it is very challenging, if not impossible, to detect
these psychological features in young infants [45,46].
Therefore, we were unable to determine whether reduced HRV
came before the development of fearfulness or not, making it
difficult to infer causation in this association. Nevertheless,
reduced HRV in infancy may be an early risk marker for the
development of psychological abnormalities, such as
fearfulness, in later life. This observation makes an important
contribution to the literature, which indicates strong
associations between low HRV and fearful temperament
(reflected in inhibited behavior, shyness, harm avoidance,
anxiety and distress) [45,47,48]. Such behavioral
characteristics have been linked to internalizing problems and
psychiatric diagnoses [49,50]. Low HRV may indicate a
vulnerability to the development of psychopathology, as
suggested by our observation that infant’s HRV is related to
later fearfulness.
Our study has a number of advantages, including a
prospective design and longitudinal assessment; assessment
of maternal HRV during the first 14 weeks of pregnancy, which
is the period of greatest fetal developmental vulnerability to
external influences; exclusion of women on antidepressants,
which is an important consideration in studies of HRV; and use
of an infant temperament (fearfulness) measure, which avoids
bias in parental perceptions.
In summary, our study showed that pregnant women with a
PAD had altered ANS function that was also found in their
infants. Alterations in the offspring were associated with
fearfulness in later infancy, suggesting transmission of a pro-
anxiety phenotype from mothers to their children.
Determination of the mechanisms of this transmission should
be an important goal of future research. Our findings may have
implications for identifying early risk factors in childhood for the
development of psychological disorders in later life. Thus,
future research might build on our findings to establish novel
risk factors for psychopathology in childhood and use those
factors to study the etiology of psychiatric disease in children.
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